CDC Group
| Development finance institution | |
| Industry | Development finance institution |
| Founded | 1948 |
| Headquarters | London, United Kingdom |
| Products | Invests equity and debt directly and through funds. |
| Website | www.cdcgroup.com |
CDC Group plc (formerly the Commonwealth Development Corporation, and previous to that, the Colonial Development Corporation) is a development finance institution owned by the UK government. The Department for International Development is responsible for CDC, with shareholder duties managed by the Shareholder Executive. It has an investment portfolio valued around £3.9 billion and since 2012 is focused on the emerging markets of South Asia and Africa.
The original Colonial Development Corporation was established as a statutory corporation in 1948 by Clement Attlee's post-war Labour government, to assist British colonies in the development of agriculture. Following the independence of many colonies, it was renamed the Commonwealth Development Corporation in 1963 and was permitted to invest outside the Commonwealth in 1969.
As part of the Commonwealth Development Corporation Act 1999, CDC was converted from a statutory corporation to a public limited company renamed CDC Group plc, with all shares owned by the UK Government.
In July 2004 CDC spun out an emerging markets private equity fund manager, Actis Capital, with a 60% stake sold to the management team. CDC remained an active sponsor of Actis's investment activities, committing the equivalent of 650 million US dollars to the firm's third fund. Following its reorganisation, CDC ceased making direct investments and became purely a fund of funds investment company. During this period it grew in value from £1.2 billion to £2.8 billion, investing in almost 1000 businesses in 70 developing countries. These businesses employed almost a million people and paid over US$3 billion a year in taxes.
CDC was the subject of extensive investigations by the magazine Private Eye, which devoted seven pages to criticising the organisation in September 2010. Amongst other allegations, it claimed that CDC had moved away from financing beneficial international development towards seeking large profits from schemes that enriched CDC's managers while bringing little or no benefit to the poor; and that when Actis was spun out it was given an "implausibly low valuation". The Actis deal was also the subject of criticism by British politicians.
...
Wikipedia